Формирование приверженности лечению при посттравматическом стрессовом расстройстве и коморбидных наркологических расстройствах

Полный текст:   Только для подписчиков

Рекомендуемое оформление библиографической ссылки:

Фадеева Е.В., Сахаров А.В. Формирование приверженности лечению при посттравматическом стрессовом расстройстве и коморбидных наркологических расстройствах // Российский психиатрический журнал. 2025. №1. С. 41-48.

Аннотация

В научном обзоре с целью анализа и систематизации литературных данных о приверженности лечению пациентов с посттравматическим стрессовым расстройством (ПТСР) и коморбидными наркологическими расстройствами был произведен поиск статей за период 1996–2024 гг. в базах данных PubMed, ResearchGate и eLIBRARY. Представлены сведения о том, что ПТСР и расстройства, связанные с употреблением психоактивных веществ, являются распространенными и рецидивирующими психическими заболеваниями, обладающими сложным этиопатогенезом со многими общими психологическими и нейробиологическими механизмами. Для пациентов с ПТСР и с зависимостью от психоактивных веществ характерны более тяжелый клинический профиль, низкая приверженность лечению, частые рецидивы наркологических заболеваний, неблагоприятный прогноз. В настоящий момент при оказании комплексной психиатрической и наркологической помощи в отношении ПТСР и наркологических расстройств используются практические приемы когнитивно-поведенческой терапии, которые одновременно должны воздействовать на симптомы и ПТСР, и расстройств, связанных с употреблением психоактивных веществ, для достижения максимально возможного терапевтического эффекта и повышения приверженности лечению.

Ключевые слова посттравматическое стрессовое расстройство; наркологические расстройства; коморбидность; приверженность лечению

Литература

1. Karavaeva TA, Vasilyeva AV, Shoigu YuS, Radionov DS. [Prevention of development of post-traumatic stress disorder in victims of emergency situations]. Sibirskiy vestnik psikhiatrii i narkologii [Siberian Herald of Psychiatry and Addiction Psychiatry]. 2023;2(119):86–95. (In Russ.) DOI: 10.26617/1810-3111-2023-2(119)-86-95 2. Suh J, Ressler KJ. Common Biological Mechanisms of Alcohol Use Disorder and Post-Traumatic Stress Disorder. Alcohol Res. 2018;39(2):131–45. PMID: 31198653 3. Harmful use of alcohol, alcohol dependence and mental health conditions: a review of the evidence for their association and integrated treatment approaches. World Health Organization. Copenhagen: WHO Regional Office for Europe; 2020. 24 p. 4. Ralevski E, Olivera-Figueroa L, Petrakis I. PTSD and comorbid AUD: A review of pharmacological and alternative treatment options. Subst Abuse Rehabil. 2024;5:25–36. DOI: 10.2147/sar.s37399 5. Vasilyeva AV, Karavaeva TA, Neznanov NG, et al. Posttravmaticheskoe stressovoe rasstroistvo v paradigme dokazatel'noi meditsiny: patogenez, klinika, diagnostika i terapiya: metodicheskie rekomendatsii. St. Petersburg: Bekhterev National Medical Research Center of Pedagogical Sciences; 2022. 33 p. (In Russ.) 6. Laciner K, Senol Y. Evaluation of Types of Traumatic Events and Comorbid Mental and Physical Diseases in Adults with Posttraumatic Stress Disorder: A Retrospective Study. Noro Psikiyatr Ars. 2024;67(3):235–40. DOI: 10.29399/npa.28651 7. Gould DA, Lubin RE, McGrew SJ, et al. The Role of Functional Health Literacy in terms of Harmful Alcohol Use in Adults with Probable Posttraumatic Stress Disorder and Alcohol Use Disorder. Res Sq [Preprint]. 2024;26:rs.3.rs-4144996. DOI: 10.21203/rs.3.rs-4144996/v1 8. Debell F, Fear NT, Head M, et al. A systematic review of the comorbidity between PTSD and alcohol misuse. Soc Psychiatry Psychiatr Epidemiol. 2014;49(9):1401–25. DOI: 10.1007/s00127-014-0855-7 9. Vinnikova MA, Severtsev VV. Sindrom zavisimosti i posttravmaticheskoe stressovoe rasstroistvo. In: Narkologiya: natsional'noe rukovodstvo. NN Ivanets, MA Vinnikova, editors. Moscow: GEOTAR-Media; 2024. р. 761–95. (In Russ.) DOI: 10.33029/9704-8363-3-NNG-2024-1-848 10. Flanagan JC, Korte KJ, Killeen TK, Back SE. Concurrent treatment of substance use and PTSD. Curr Psychiatry Rep. 2016;18(8):70. DOI: 10.1007/s11920-016-0709-y 11. Gandelman EM, Miller SA, Back SE. Imaginal exposure processing during Concurrent Treatment of PTSD and Substance Use Disorders using Prolonged Exposure (COPE) therapy: Examination of linguistic markers of cohesiveness. J Trauma Stress. 2022;35(2):682–93. DOI: 10.1002/jts.22786 12. Kaier E, Possemato K, Lantinga LJ, et al. Associations between PTSD and healthcare utilization among OEF/OIF veterans with hazardous alcohol use. Traumatology. 2014;20(3):142–9. DOI: 10.1037/h0099399 13. Bowe A, Rosenheck R. PTSD and substance use disorder among veterans: characteristics, service utilization and pharmacotherapy. J Dual Diagn. 2015;11(1):22–32. DOI: 10.1080/15504263.2014.989653 14. Roberts NP, Roberts PA, Jones N, Bisson JI. Psychological interventions for post-traumatic stress disorder and comorbid substance use disorder: A systematic review and meta-analysis. Clin Psychol Rev. 2015;38:25–38. DOI: 10.1016/j.cpr.2015.02.007 15. Shorter D, Hsieh J, Kosten TR. Pharmacologic management of comorbid post-traumatic stress disorder and addictions. Am J Addict. 2015;24(8):705–12. DOI: 10.1111/ajad.12306 16. Stewart SH, Conrod PJ. Psychosocial models of functional associations between posttraumatic stress disorder and substance use disorder. In: Trauma and substance abuse: causes, consequences, and treatment of comorbid disorders. P Ouimette, PJ Brown, editors. Washington. DC: American Psychological Association; 2003. 315 p. 17. Paltell KC, Smith RL, Kansky J, et al. Posttraumatic stress disorder symptoms, relationship quality, and risky alcohol use among trauma-exposed students. Addict Behav. 2020;102:106216. DOI: 10.1016/j.addbeh.2019.106216 18. Kessler RC, Demler O, Frank RG, et al. Prevalence and treatment of mental disorders, 1990 to 2003. N Engl J Med. 2005;352(24):2515–23. DOI: 10.1056/NEJMsa043266 19. Ouimette PC, Read JP, Wade M, Tirone V. Modeling associations between posttraumatic stress symptoms and substance use. Addict Behav. 2010;35(1):64–7. DOI: 10.1016/j.addbeh.2009.08.009 20. Leeies M, Pagura J, Sareen J, Bolton JM. The use of alcohol and drugs to self-medicate symptoms of posttraumatic stress disorder. Depress Anxiety. 2010;27(8):731–6. DOI: 10.1002/da.20677 21. Logrip ML, Zorrilla EP, Koob GF. Stress modulation of drug self-administration: implications for addiction comorbidity with posttraumatic stress disorder. Neuropharmacology. 2012;62(2):552–64. DOI: 10.1016/j.neuropharm.2011.07.007 22. Suh J, Ressler KJ. Common Biological Mechanisms of Alcohol Use Disorder and Post-Traumatic Stress Disorder. Alcohol Res. 2018;39(2):131–45. PMID: 31198653 23. Lee RS, Oswald LM, Wand GS. Early Life Stress as a Predictor of Co-Occurring Alcohol Use Disorder and Post-Traumatic Stress Disorder. Alcohol Res. 2018;39(2):147–59. PMID: 31198654 24. Borgonetti V, Cruz B, Vozella V, et al. IL-18 Signaling in the Rat Central Amygdala Is Disrupted in a Comorbid Model of Post-Traumatic Stress and Alcohol Use Disorder. Cells. 2023;12(15):1943. DOI: 10.3390/cells12151943 25. Cruz B, Vozella V, Carper BA, et al. FKBP5 inhibitors modulate alcohol drinking and trauma-related behaviors in a model of comorbid post-traumatic stress and alcohol use disorder. Neuropsychopharmacology. 2023;48(8):1144–54. DOI: 10.1038/s41386-022-01497-w 26. Dworkin ER, Bergman HE, Walton TO, et al. Co-Occurring Post-Traumatic Stress Disorder and Alcohol Use Disorder in U.S. Military and Veteran Populations. Alcohol Res. 2018;39(2):161–9. PMID: 31198655 27. Neupane SP, Bramness JG, Lien L. Comorbid post-traumatic stress disorder in alcohol use disorder: relationships to demography, drinking and neuroimmune profile. BMC Psychiatry. 2017;17(1):312. DOI: 10.1186/s12888-017-1479-8 28. Izbrannye lektsii po klinicheskoi, ekstremal'noi i voennoi psikhiatrii: uchebnoe posobie. VK Shamrey, AA Marchenko, editors. St. Petersburg: VMedA; 2020. 340 р. (In Russ.) 29. Psikhiatriya voin i katastrof. VK Shamrey, editor. St. Petersburg: SpetsLit; 2015. 431 р. (In Russ.) 30. Patel H, O'Connor C, Andrews K, et al. Dissociative symptomatology mediates the relation between posttraumatic stress disorder severity and alcohol-related problems. Alcohol Clin Exp Res. 2022;46(2):289–99. DOI: 10.1111/acer.14764 31. Reznik AM, Syunyakov TS, Arbuzov AL. Alcohol addiction in war veterans treated in a in-patient psychiatric facility: incidence, comorbidity with PTSD symptoms, association with combat stressors. Consortium Psychiatricum. 2022;3(3):73–89. DOI: 10.17816/CP188 32. Houghton DC, Spratt HM, Keyser-Marcus L, et al. Behavioral and neurocognitive factors distinguishing post-traumatic stress comorbidity in substance use disorders. Transl Psychiatry. 2023;13(1):296. DOI: 10.1038/s41398-023-02591-3 33. Roberts NP, Lotzin A, Schäfer I. A systematic review and meta-analysis of psychological interventions for comorbid post-traumatic stress disorder and substance use disorder. Eur J Psychotraumatol. 2022;13(1):2041831. DOI: 10.1080/20008198.2022.2041831 34. Gorodnova MYu. [Actual issues of the psychology of adherence to treatment in drug addicts and the psychology of the treatment environment]. Meditsinskaya psikhologiya v Rossii [Medical Psychology in Russia]. 2012;5(16). (In Russ.) URL: http://medpsy.ru (accessed on: 17.09.2024). 35. Lukina YuV, Kutishenko NP, Martsevich SYu, et al. [Adherence to drug therapy in patients with chronic non-communicable diseases: methodical recommendations]. Profilakticheskaya meditsina [Preventive Medicine]. 2020;23(3–2):42–60. (In Russ.) DOI: 10.17116/profmed20202303242 36. Belokolodov VV, Bril' MS, Obidin IYu, Bekreneva YuS. [Resistance to treatment in case of refusal from use of psychoactive substances as a reaction to a stressful situation]. Vestnik Omskogo universiteta. Seriya: Psikhologiya [Bulletin of Omsk University. Series: Psychology]. 2021;(4):6–14. (In Russ.) DOI: 10.24147/2410-6364.2021.4.6-14 37. World Health Organization. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003. 196 p. 38. Ivanets NN, Vinnikova MA. Kontseptsiya terapii narkologicheskikh zabolevanii. In: Narkologiya: natsional'noe rukovodstvo. NN Ivanets, MA Vinnikova, editors. Moscow: GEOTAR-Media; 2024. р. 601–9. (In Russ.) DOI: 10.33029/9704-8363-3-NNG-2024-1-848 39. Agibalova TV, Rychkova OV, Tuchin PV. Motivatsionnaya psikhoterapiya narkologicheskikh patsientov. In: Narkologiya: natsional'noe rukovodstvo. NN Ivanets, MA Vinnikova, editors. Moscow: GEOTAR-Media; 2024. р. 668–74. (In Russ.) DOI: 10.33029/9704-8363-3-NNG-2024-1-848 40. Dyar C, Kaysen D. Event-level positive and negative reinforcement risk factors for alcohol use: Moderation by individual-level alcohol consequences and post-traumatic stress disorder symptom severity. Alcohol Clin Exp Res. 2023;47(11):2068–80. DOI: 10.1111/acer.15188 41. Najavits LM, Weiss RD, Liese BS. Group cognitive-behavioral therapy for women with PTSD and substance use disorder. J Subst Abuse Treat. 1996;13(1):13–22. DOI: 10.1016/0740-5472(95)02025-x 42. Gully BJ, Eaton E, Capone C, Haass-Koffler CL. Treating posttraumatic stress disorder and alcohol use disorder comorbidity: Current pharmacological therapies and the future of MDMA-integrated psychotherapy. J Psychopharmacol. 2023;37(12):1182–9. DOI: 10.1177/02698811231200880 43. Back SE, Waldrop AE, Brady KT, Hien D. Evidenced-based time-limited treatment of co- occurring substance-use disorders and civilian-related posttraumatic stress disorder. Brief Treat Crisis Interv. 2006;6(4):283. DOI: 10.1093/brief-treatment/mhl013 44. Back SE, Brady KT, Sonne SC, Verduin ML. Symptom improvement in co-occurring PTSD and alcohol dependence. J Nerv Ment Dis. 2006;194(9):690–6. DOI: 10.1097/01.nmd.0000235794.12794.8a 45. Brown PJ, Stout RL, Gannon-Rowley J. 15 substance use disorder-PTSD comorbidity: patients’ perceptions of symptom interplay and treatment issues. J Subst Abuse Treat. 1998;15(5):445–8. DOI: 10.1016/s0740-5472(97)00286-9 46. Karaush IS, Abramov SV. Sovremennye psihoterapevticheskie podhody k lecheniyu posttravmaticheskogo stressovogo rasstrojstva. Rossiiskii psikhiatricheskii zhurnal [Russian Journal of Psychiatry]. 2024;(4):55–66. (In Russ.) 47. Mills KL, Teesson M, Back SE, et al. Integrated exposure-based therapy for co-occurring post-traumatic stress disorder and substance dependence – a randomized controlled trial exposure therapy for PTSD and substance dependence. JAMA. 2012;308(7):690–9. DOI: 10.1001/jama.2012.9071 48. Hien DA, Papini S, Saavedra LM, et al. Project harmony: A systematic review and network meta-analysis of psychotherapy and pharmacologic trials for comorbid posttraumatic stress, alcohol, and other drug use disorders. Psychol Bull. 2024;150(3):319–53. DOI: 10.1037/bul0000409 49. Back SE, Killeen T, Badour CL, et al. Concurrent treatment of substance use disorders and PTSD using prolonged exposure: A randomized clinical trial in military veterans. Addict Behav. 2019;90:369–77. DOI: 10.1016/j.addbeh.2018.11.032 50. Back SE, Foa EBTK, Mills K, et al. Concurrent Treatment of PTSD and Substance Use Disorders using Prolonged Exposure (COPE): Therapist Guide. New York: Oxford University Press; 2015. 256 p. DOI: 10.1093/med:psych/9780199334537.001.0001 51. Hien DA, Wells EA, Jiang H, et al. Multisite randomized trial of behavioral interventions for women with co-occurring PTSD and substance use disorders. J Consult Clin Psychol. 2009;77(4):607–19. DOI: 10.1037/a0016227

Метрики статей

Загрузка метрик ...

Metrics powered by PLOS ALM